FF hiPS:Feeder-free Human iPS cells (201B7 cell line)
Protocol
Results
Noise reduction: 6
Roundness: 60%
Min. cell size (μm): 3
Max. cell size (μm): 60
Declustering level: Medium
Total cell conc. (cells/ml): 1.50 x 106
Live cell conc. (cells/ml): 1.38 x 106
Dead cell conc. (cells/ml): 1.19 x 105
Viability (%): 92.0
Average cell size (μm): 15.9
Total cell conc. (cells/ml): 1.03 x 106
Live cell conc. (cells/ml): 9.37 x 105
Dead cell conc. (cells/ml): 9.72 x 104
Viability (%): 90.6
Average cell size (μm): 19.6
A549: Human lung carcinoma
Protocol
Results
Noise reduction: 5
Roundness: 60%
Min. cell size (μm): 3
Max. cell size (μm): 60
Declustering level: Medium
Total cell conc. (cells/ml): 1.09 x 106
Live cell conc. (cells/ml): 1.07 x 106
Dead cell conc. (cells/ml): 1.78 x 104
Viability (%): 98.4
Average cell size (μm): 17.5
AsPC-1: Human pancreatic adenocarcinoma
Protocol
Results
Noise reduction: 5
Roundness: 60%
Min. cell size (μm): 3
Max. cell size (μm): 60
Declustering level: High
Total cell conc. (cells/ml): 7.51 x 105
Live cell conc. (cells/ml): 7.19 x 105
Dead cell conc. (cells/ml): 3.17 x 104
Viability (%): 95.8
Average cell size (μm): 10.7
C6: Rat glioma
Protocol
Results
Noise reduction: 5
Roundness: 60%
Min. cell size (μm): 3
Max. cell size (μm): 60
Declustering level: Medium
Total cell conc. (cells/ml): 1.31 x 106
Live cell conc. (cells/ml): 1.22 x 106
Dead cell conc. (cells/ml): 8.91 x 104
Viability (%): 93.2
Average cell size (μm): 12.1
Capan-2: Human pancreatic adenocarcinoma
Protocol
Results
Noise reduction: 5
Roundness: 60%
Min. cell size (μm): 3
Max. cell size (μm): 60
Declustering level: Medium
Total cell conc. (cells/ml): 1.04 x 106
Live cell conc. (cells/ml): 1.00 x 106
Dead cell conc. (cells/ml): 3.61 x 104
Viability (%): 96.5
Average cell size (μm): 13.4
DU 145: Human prostate carcinoma
Protocol
Results
Noise reduction: 5
Roundness: 60%
Min. cell size (μm): 3
Max. cell size (μm): 60
Declustering level: Medium
Total cell conc. (cells/ml): 1.86 x 106
Live cell conc. (cells/ml): 1.80 x 106
Dead cell conc. (cells/ml): 5.34 x 104
Viability (%): 97.1
Average cell size (μm): 14.3
293-GFP: HEK293 stably expressing GFP
Protocol
Results
Noise reduction: 5
Roundness: 60%
Min. cell size (μm): 3
Max. cell size (μm): 60
Declustering level: Medium
Total cell conc. (cells/ml): 1.84 x 106
Live cell conc. (cells/ml): 1.82 x 106
Dead cell conc. (cells/ml): 2.23 x 104
Viability (%): 98.8
Average cell size (μm): 11.3
H1299: Human non-small cell lung carcinoma
Protocol
Results
Noise reduction: 5
Roundness: 60%
Min. cell size (μm): 3
Max. cell size (μm): 60
Declustering level: Medium
Total cell conc. (cells/ml): 4.14 x 105
Live cell conc. (cells/ml): 3.52 x 105
Dead cell conc. (cells/ml): 6.23 x 104
Viability (%): 84.9
Average cell size (μm): 19.5
H4: Human neuroglioma
Protocol
Results
Noise reduction: 5
Roundness: 60%
Min. cell size (μm): 3
Max. cell size (μm): 60
Declustering level: Medium
Total cell conc. (cells/ml): 2.08 x 105
Live cell conc. (cells/ml): 1.44 x 105
Dead cell conc. (cells/ml): 6.32 x 104
Viability (%): 69.6%
Average cell size (μm): 12.8
HCT116: Human colorectal carcinoma
Protocol
Results
Noise reduction: 5
Roundness: 60%
Min. cell size (μm): 3
Max. cell size (μm): 60
Declustering level: Medium
Total cell conc. (cells/ml): 1.34 x 106
Live cell conc. (cells/ml): 1.32 x 106
Dead cell conc. (cells/ml): 1.81 x 104
Viability (%): 98.7
Average cell size (μm): 12.2
HeLa: Human cervical carcinoma*
Protocol
Results
Noise reduction: 5
Roundness: 60%
Min. cell size (μm): 3
Max. cell size (μm): 60
Declustering level: Medium
Total cell conc. (cells/ml): 8.98 x 105
Live cell conc. (cells/ml): 8.11 x 105
Dead cell conc. (cells/ml): 8.69 x 104
Viability (%): 90.3
Average cell size (μm): 17.6
Hep3B: Human hepatocellular carcinoma
Protocol
Results
Noise reduction: 5
Roundness: 60%
Min. cell size (μm): 3
Max. cell size (μm): 60
Declustering level: Medium
Total cell conc. (cells/ml): 1.54 x 106
Live cell conc. (cells/ml): 1.49 x 106
Dead cell conc. (cells/ml): 5.87 x 104
Viability (%): 96.2
Average cell size (μm): 14.9
HL-60: Human acute promyelocytic leukemia
Protocol
Results
Noise reduction: 5
Roundness: 60%
Min. cell size (μm): 3
Max. cell size (μm): 60
Declustering level: Medium
Total cell conc. (cells/ml): 1.57 x 106
Live cell conc. (cells/ml): 1.45 x 106
Dead cell conc. (cells/ml): 1.23 x 105
Viability (%): 92.2
Average cell size (μm): 14.9
Hs 578T: Human mammary carcinoma
Protocol
Results
Noise reduction: 5
Roundness: 60%
Min. cell size (μm): 3
Max. cell size (μm): 60
Declustering level: Medium
Total cell conc. (cells/ml): 1.13 x 106
Live cell conc. (cells/ml): 8.72 x 105
Dead cell conc. (cells/ml): 2.62 x 105
Viability (%): 76.9
Average cell size (μm): 16.5
MCF7: Human breast adenocarcinoma
Protocol
Results
Noise reduction: 5
Roundness: 60%
Min. cell size (μm): 3
Max. cell size (μm): 60
Declustering level: Medium
Total cell conc. (cells/ml): 4.74 x 105
Live cell conc. (cells/ml): 4.43 x 105
Dead cell conc. (cells/ml): 4.07 x 104
Viability (%): 91.4
Average cell size (μm): 16.2
NIH3T3: Mouse embryonic fibroblast
Protocol
Results
Noise reduction: 5
Roundness: 60%
Min. cell size (μm): 3
Max. cell size (μm): 60
Declustering level: Medium
Total cell conc. (cells/ml): 1.52 x 106
Live cell conc. (cells/ml): 1.33 x 106
Dead cell conc. (cells/ml): 1.96 x 105
Viability (%): 87.1
Average cell size (μm): 14.1
PANC-1: Human pancreatic ductal carcinoma
Protocol
Results
Noise reduction: 5
Roundness: 60%
Min. cell size (μm): 3
Max. cell size (μm): 60
Declustering level: High
Total cell conc. (cells/ml): 1.23 x 106
Live cell conc. (cells/ml): 1.21 x 105
Dead cell conc. (cells/ml): 2.26 x 104
Viability (%): 98.2
Average cell size (μm): 15.3
PC-3: Human prostate adenocarcinoma
Protocol
Results
Noise reduction: 5
Roundness: 60%
Min. cell size (μm): 3
Max. cell size (μm): 60
Declustering level: Medium
Total cell conc. (cells/ml): 1.36 x 106
Live cell conc. (cells/ml): 1.33 x 106
Dead cell conc. (cells/ml): 3.16 x 104
Viability (%): 97.7
Average cell size (μm): 17.2
STO: Mouse embryonic fibroblast
Protocol
Results
Noise reduction: 5
Roundness: 0%
Min. cell size (μm): 3
Max. cell size (μm): 60
Declustering level: Medium
Total cell conc. (cells/ml): 1.78 x 106
Live cell conc. (cells/ml): 1.50 x 106
Dead cell conc. (cells/ml): 2.81 x 105
Viability (%): 84.2
Average cell size (μm): 13.1
U-2 OS: Human osteosarcoma
Protocol
Results
Noise reduction: 5
Roundness: 60%
Min. cell size (μm): 3
Max. cell size (μm): 60
Declustering level: Medium
Total cell conc. (cells/ml): 7.66 x 105
Live cell conc. (cells/ml): 7.21 x 105
Dead cell conc. (cells/ml): 4.45 x 104
Viability (%): 94.2
Average cell size (μm): 16.0
U937: Human lymphoma
Protocol
Results
Noise reduction: 5
Roundness: 40%
Min. cell size (μm): 3
Max. cell size (μm): 60
Declustering level: Medium
Total cell conc. (cells/ml): 1.22 x 106
Live cell conc. (cells/ml): 1.12 x 106
Dead cell conc. (cells/ml): 1.02 x 105
Viability (%): 91.6
Average cell size (μm): 13.4
*Although it became one of the most important cell lines in medical research, it’s imperative that we recognize Henrietta Lacks’ contribution to science happened without her consent. This injustice, while leading to key discoveries in immunology, infectious disease, and cancer, also raised important conversations about privacy, ethics, and consent in medicine.
To learn more about the life of Henrietta Lacks and her contribution to modern medicine, click here. http://henriettalacksfoundation.org/
Not Available in Your Country
Sorry, this page is not
available in your country.